Last update April 16, 2015

حمض فلوفيناميك

Very Low Risk

Safe. Compatible. Minimal risk for breastfeeding and infant.

It is a non-steroidal anti-inflammatory topically used which is chemically related to Mefenamic acid. There are also formulations for oral use.

Excreted into breast milk in a clinically non-significant amount even after oral administration.

Because a low dose used and a poor absorption into the plasma of most dermatological preparations for topical use, its appearance in the breast milk is even less likely.

The American Academy of Pediatrics rated it as usual compatible with breastfeeding.

Alternatives

We do not have alternatives for حمض فلوفيناميك since it is relatively safe.

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

حمض فلوفيناميك is also known as Flufenamic Acid. Here it is a list of alternative known names::


Group

حمض فلوفيناميك belongs to this group or family:

Tradenames

Main tradenames from several countries containing حمض فلوفيناميك in its composition:

Pharmacokinetics

Variable Value Unit
Molecular weight 281 daltons

References

  1. Köhler G, Tressel W, Dell HD, Doersing M, Fischer W, Kamp R, Langer M, Richter B, Wirzbach E. [Plasma- and tissue concentrations following intramuscular administration of etofenamat. Pharmacokinetics of etofenamat and flufenamic acid in plasma, synovium, and tissues of patients with chronic polyarthritis after administration of an oily solution of etofenamat]. Arzneimittelforschung. 1992 Abstract
  2. Lentjes EG, van Ginneken CA. Pharmacokinetics of flufenamic acid in man. Int J Clin Pharmacol Ther Toxicol. 1987 Abstract
  3. Buchanan RA, Eaton CJ, Koeff ST, Kinkel AW. The breast milk excretion on flufenamic acid. Curr Ther Res Clin Exp. 1969 Abstract

Total visits

2,157

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2006 of United States of America

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM